0001127602-22-021087.txt : 20220816 0001127602-22-021087.hdr.sgml : 20220816 20220816163356 ACCESSION NUMBER: 0001127602-22-021087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220816 DATE AS OF CHANGE: 20220816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KROLL MARK W CENTRAL INDEX KEY: 0001259254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 221170598 MAIL ADDRESS: STREET 1: PO BOX 23 CITY: CRYSTAL BAY STATE: MN ZIP: 55323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0401 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-08-15 0000313143 HAEMONETICS CORP HAE 0001259254 KROLL MARK W 125 SUMMER STREET BOSTON MA 02110 1 Common Stock 2022-08-15 4 S 0 8016 73.71 D 16231 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This number includes unvested restricted stock units previously reported. /s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll 2022-08-16